Johns Hopkins Medicine: Keys To Making Immunotherapy Work Against Pancreatic Cancer Found In Tumor Microenvironment
January 27, 2023
January 27, 2023
BALTIMORE, Maryland, Jan. 27 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
A new study that analyzed the tumor microenvironment of pancreatic cancer revealed the cause of tumor cell resistance to immunotherapy and resulted in new treatment strategies.
This study, led by researchers at the Johns Hopkins Kimmel Cancer Center, is the latest from an ongoing platform trial formed in 2015 to study immunotherapy treatments before surgery (neoadjuvant) a . . .
A new study that analyzed the tumor microenvironment of pancreatic cancer revealed the cause of tumor cell resistance to immunotherapy and resulted in new treatment strategies.
This study, led by researchers at the Johns Hopkins Kimmel Cancer Center, is the latest from an ongoing platform trial formed in 2015 to study immunotherapy treatments before surgery (neoadjuvant) a . . .